Want to see HK:1672 full AI Analyst Report?
Ascletis Pharma, Inc. (1672) Financial Statements
9 Followers
Ascletis Pharma, Inc. Financial Overview
Ascletis Pharma, Inc.'s market cap is currently ¥4.53B. The company's EPS TTM is ¥-0.59; its P/E ratio is -6.58; Ascletis Pharma, Inc. is estimated to report earnings on March 30, 2027, and the estimated EPS forecast is ¥-0.49. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ¥ 2.03M | ¥ 1.28M | ¥ 56.60M | ¥ 54.09M | ¥ 76.88M |
| Gross Profit | ¥ 527.00K | ¥ 735.00K | ¥ 25.99M | ¥ -24.69M | ¥ 39.17M |
| Operating Income | ¥ -483.76M | ¥ -295.42M | ¥ -300.21M | ¥ -343.98M | ¥ -224.97M |
| EBITDA | ¥ -466.92M | ¥ -384.18M | ¥ -126.09M | ¥ -284.50M | ¥ -169.35M |
| Net Income | ¥ -359.88M | ¥ -300.94M | ¥ -144.72M | ¥ -314.84M | ¥ -199.02M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ¥ 1.90B | ¥ 1.95B | ¥ 2.30B | ¥ 2.48B | ¥ 2.50B |
| Total Assets | ¥ 2.07B | ¥ 2.12B | ¥ 2.49B | ¥ 2.66B | ¥ 2.83B |
| Total Debt | ¥ 5.16M | ¥ 7.63M | ¥ 8.42M | ¥ 4.24M | ¥ 2.75M |
| Net Debt | ¥ -1.44B | ¥ -858.10M | ¥ -321.70M | ¥ -2.47B | ¥ -2.49B |
| Total Liabilities | ¥ 129.93M | ¥ 158.41M | ¥ 148.94M | ¥ 117.16M | ¥ 100.89M |
| Stockholders' Equity | ¥ 1.94B | ¥ 1.97B | ¥ 2.34B | ¥ 2.54B | ¥ 2.73B |
| Cash Flow | |||||
| Free Cash Flow | ¥ -330.83M | ¥ -343.73M | ¥ -163.32M | ¥ -156.85M | ¥ -154.13M |
| Operating Cash Flow | ¥ -329.23M | ¥ -341.58M | ¥ -144.16M | ¥ -142.45M | ¥ -146.93M |
| Investing Cash Flow | ¥ 565.97M | ¥ 978.91M | ¥ 149.84M | ¥ -1.30B | ¥ -274.49M |
| Financing Cash Flow | ¥ 336.29M | ¥ -103.51M | ¥ -81.50M | ¥ -1.42M | ¥ -31.10M |
Currency in CNY
